β-thalassemia IVS-I-110(G>A) mutation Reference Standard
CBPD0002
詢(xún) 價(jià)
索取COA
產(chǎn)品描述
產(chǎn)品數(shù)據(jù)庫(kù)
| Introduction | |
| Format | Genomic DNA |
| Description | β-thalassemia (β-mediterraneananemia) refers to the A group of hemoglobinopathies in which synthesis is partially or completely inhibited. |
| Technical Data | |
| Variation site | IVS-I-110(G>A) |
| DNA Change | c.93-21G>A |
| Zygosity | Homozygous |
| Allelic Frequency | 100% |
| Transcript | NM_000518.5 |
| Chr position(GRCh37) | Chr11:5248050C>T |
| Buffer | Tris-EDTA |
| Product Information | |
| Intended Use | Research Use Only |
| Unit Size | 1ug |
| Concentration | Download for COA |
| Purofication | Download for COA |
| DNA electrophoresis | Download for COA |
| Sanger sequencing |
|
| Storage | 2-8℃ |
| Expiry | 36 months from the date of manufacture |
